Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Fructose-1,6-bisphosphate aldolase (EC 188.8.131.52) is a tetrameric glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Zusätzlich bieten wir Ihnen Aldolase B, Fructose-Bisphosphate Antikörper (93) und Aldolase B, Fructose-Bisphosphate Proteine (28) und viele weitere Produktgruppen zu diesem Protein an.
Showing 5 out of 18 products:
Silencing Aldolase B activated epithelial markers and repressed mesenchymal markers, indicating inactivation of Aldolase B may lead to inhibition of epithelial-mesenchymal transition
The downregulation of ALDOB could indicate a poor prognosis for HCC (zeige FAM126A ELISA Kits) patients, and therefore, ALDOB might be considered a prognostic biomarker for HCC (zeige FAM126A ELISA Kits), especially at the early stage.
ALDOC (zeige ALDOC ELISA Kits), Aldolase (zeige ALD ELISA Kits) A (ALDOA (zeige ALDOA ELISA Kits)) and Aldolase B (ALDOB) activate Wnt (zeige WNT2 ELISA Kits) signaling.
Single nucleotide polymorphisms in ALDOB, MAP3K1 (zeige MAP3K1 ELISA Kits), and MEF2C (zeige MEF2C ELISA Kits) are associated with cataract.
both of exogenous and endogenous ALDOB proteins bind to hepatitis B surface antigen and colocalize in the cytoplasm in vitro and inhibit apoptosis of cisplatin-induced HepG2 cells.
Efficient inhibition of aldolase B can prevent high glucose-induced overproduction of methylglyoxal and related cellular dysfunction in endothelial cells.
Aldolase B with the A149P substitution has activity that is <100-fold that of the wild type.
These novel mutations in ALDOB represent 2% of alleles in American HFI (zeige MIP ELISA Kits) (hereditary fructose intolerance) patients, with IVS1+1G>C representing a significantly higher allele frequency (6%) among HFI (zeige MIP ELISA Kits) patients of Hispanic and African-American ethnicity.
This is the first report of six unrelated patients sharing the same ALDOB deletion, thus indicating a founder effect for this allele.
Biochemical study of defective aldolase B enzymes is key to revealing the molecular basis of the disease and providing a stronger basis for improved treatment and diagnosis
characterization of the aldolase B gene enhancer
NKCC2 (zeige SLC12A1 ELISA Kits) surface expression in mammalian cells is shown to be downregulated by a novel interaction with aldolase B
Fructose-1,6-bisphosphate aldolase (EC 184.108.40.206) is a tetrameric glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Vertebrates have 3 aldolase isozymes which are distinguished by their electrophoretic and catalytic properties. Differences indicate that aldolases A, B, and C are distinct proteins, the products of a family of related 'housekeeping' genes exhibiting developmentally regulated expression of the different isozymes. The developing embryo produces aldolase A, which is produced in even greater amounts in adult muscle where it can be as much as 5% of total cellular protein. In adult liver, kidney and intestine, aldolase A expression is repressed and aldolase B is produced. In brain and other nervous tissue, aldolase A and C are expressed about equally. There is a high degree of homology between aldolase A and C. Defects in ALDOB cause hereditary fructose intolerance.
aldolase B, fructose-bisphosphate
, Fructose-bisphosphate aldolase B
, fructose-bisphosphate aldolase B-like
, aldolase 2
, aldolase B, fructose-bisphosphatase
, fructose-bisphosphate aldolase B
, liver-type aldolase
, fructose 1,6, bisphosphate aldolase
, aldolase 2, B isoform
, Aldolase B fructose-biphosphate
, Aldolase B, fructose-biphosphate